טוען...
Liraglutide therapy beyond glycemic control: an observational study in Indian patients with type 2 diabetes in real world setting
BACKGROUND: Liraglutide is an analog of human glucagon-like peptide-1 (GLP-1) and acts as a GLP-1 receptor agonist. Liraglutide is presently used in the treatment of selected patients with type 2 diabetes mellitus (T2DM). OBJECTIVE: To assess efficacy and safety of liraglutide in, overweight and obe...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3333831/ https://ncbi.nlm.nih.gov/pubmed/22536087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S27886 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|